Condition
Squamous Cell Cancer of Head and Neck (SCCHN) clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Squamous Cell Cancer of Head and Neck (SCCHN) clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Canada (1), China (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 3Countries
Newest Squamous Cell Cancer of Head and Neck (SCCHN) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia | Phase 1 | Minneapolis, Minnesota and 1 other locations | Recruiting | Oct 28, 2026 |
| Nivolumab-IRDyE800CW imaging agent used before surgery in head and neck cancer | Phase 1 | Nashville, Tennessee | Recruiting | Mar 10, 2026 |
| MRI-guided focused ultrasound mesencephalotomy for opioid-resistant head, neck, and brachial cancer pain | — | Boston, Massachusetts and 5 other locations | Recruiting | Feb 12, 2026 |
| Daily adaptive radiotherapy to spare the submandibular gland in head and neck cancer | — | Toronto, Ontario | Recruiting | Jan 16, 2026 |
| Postoperative cisplatin with radiation versus radiation alone for intermediate‑risk head and neck squamous cell carcinoma | Phase 3 | Guangzhou, Guangdong and 6 other locations | Recruiting | Aug 15, 2025 |
All recruiting trials (5)
-
Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia
This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.
-
Nivolumab-IRDyE800CW imaging agent used before surgery in head and neck cancer
This early-stage trial tests whether nivolumab labeled with IRDye800CW can safely be given before surgery to see if it helps image head and neck squamous cell carcinoma.
-
MRI-guided focused ultrasound mesencephalotomy for opioid-resistant head, neck, and brachial cancer pain
This study will try MRI-guided focused ultrasound to make a tiny, precise lesion in the midbrain to relieve severe, opioid-resistant head, neck, or brachial cancer pain.
-
Daily adaptive radiotherapy to spare the submandibular gland in head and neck cancer
This study tests whether daily adaptive radiotherapy can better protect the submandibular gland and reduce dry mouth for adults having curative radiotherapy for head and neck squamous cell carcinoma.
-
Postoperative cisplatin with radiation versus radiation alone for intermediate‑risk head and neck squamous cell carcinoma
This test sees if adding cisplatin chemotherapy to radiation after surgery helps people with intermediate‑risk head and neck squamous cell carcinoma stay cancer‑free longer and live longer.
Related topics
Quick answers
How many Squamous Cell Cancer of Head and Neck (SCCHN) clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Canada (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.